Sunday, June 19, 2011

Biotech Kept VenCap

"That’s because nearly half of biotechnology investment money last year was raised through debt financing deals by larger mature companies, which used it to buy back their own shares, boosting earnings and share prices....

--more--"  

Related:  VenCap Vroom-Vroom

Yeah, you are the big loser again, Americans.